🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07474714
Starting soon Phase 3

Hyaluronic Acid Injection in Idiopathic Carpal Tunnel Syndrome; is it Effective as Local Corticosteroids

NCT07474714 · tracked via the Priya Life Science Egypt tracker
Phase
Phase 3
Started
2026-02
Last updated
2026-03-17

Condition(s) studied

Carpal Tunnel Syndrome (CTS)

Investigational drug(s) / intervention(s)

Low Molecular Weight Hyaluronic Acidcorticosteroid

Low Molecular Weight Hyaluronic Acid: Ultrasound-guided perineural injection of low molecular weight Hyaluronic Acid.

corticosteroid: Ultrasound-guided perineural injection of corticosteroids

Study summary

This study compares the effectiveness of two types of local injections-Hyaluronic Acid (HA) and corticosteroids-for treating mild to moderate idiopathic Carpal Tunnel Syndrome (CTS). Sixty adult patients will be assigned to receive one of the two injections under ultrasound guidance. The goal is to see if HA is as effective as the standard corticosteroid treatment in improving symptoms and nerve function over a 3-month follow-up period.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Numbness or pain in the Median Nerve (MN) distribution. 2. Nerve conduction studies (NCS) consistent with CTS as per the AANEM guidelines. 3. An MN cross-sectional area (CSA) at the wrist \>12 mm² Exclusion Criteria: 1. Patients with severe symptoms (indication for surgery). 2. Patients who show improvement on medical treatment. 3. Patients with previous surgical or injectional CTS treatment. 4. Coexistence of brachial plexopathy, or thoracic outlet syndrome. 5. Patients with infection at the site of injection.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Minia University Hosopital Minya Egypt

More Minia University Hospital trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07474714 on ClinicalTrials.gov ↗ ← All trials in Egypt